Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 60 entries
View as:

UV Sensor in Patients With Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT05481073 Org: User:
Start: 06/13/22 End: 09/01/22 Due: 09/01/23

Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test

Phase: N/A Priority: Normal
NCT ID: NCT01462643 Org: User:
Start: 08/31/11 End: 09/30/11 Due: 09/30/12

A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine

Phase: N/A Priority: Normal
NCT ID: NCT05149313 Org: User:
Start: 12/23/21 End: 05/07/24 Due: 05/07/25

Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)

Phase: N/A Priority: Normal
NCT ID: NCT04229836 Org: User:
Start: 12/17/19 End: 11/15/21 Due: 11/15/22

Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections

Phase: N/A Priority: Normal
NCT ID: NCT01102387 Org: User:
Start: 02/28/10 End: 07/31/11 Due: 07/31/12

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test

Phase: N/A Priority: Normal
NCT ID: NCT01360944 Org: User:
Start: 05/31/11 End: 06/30/11 Due: 06/30/12

A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp

Phase: N/A Priority: Normal
NCT ID: NCT05387525 Org: User:
Start: 10/24/22 End: 07/31/27 Due: 07/31/28

Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study

Phase: N/A Priority: Normal
NCT ID: NCT04823247 Org: User:
Start: 11/22/21 End: 01/09/25 Due: 01/09/26

Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT04203693 Org: User:
Start: 10/30/19 End: 04/30/24 Due: 04/30/25

Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test

Phase: N/A Priority: Normal
NCT ID: NCT02111499 Org: User:
Start: 03/31/14 End: 06/30/14 Due: 06/30/15

Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT01538225 Org: User:
Start: 04/30/12 End: 11/30/13 Due: 11/30/14

Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT01265602 Org: User:
Start: 11/30/10 End: 03/31/12 Due: 03/31/13

Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT00991861 Org: User:
Start: 08/31/09 End: 02/28/10 Due: 02/28/11

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02959970 Org: User:
Start: 10/31/16 End: 03/09/18 Due: 03/09/19

Efficacy and Safety of Tazarotene Gel in Nail Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02235480 Org: User:
Start: 02/28/14 End: 05/31/15 Due: 05/31/16

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Phase: N/A Priority: Normal
NCT ID: NCT02320149 Org: User:
Start: 12/18/14 End: 02/01/17 Due: 02/01/18

Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses

Phase: N/A Priority: Normal
NCT ID: NCT02289768 Org: User:
Start: 10/31/14 End: 09/30/15 Due: 09/30/16

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)

Phase: N/A Priority: Normal
NCT ID: NCT03285490 Org: User:
Start: 09/15/17 End: 04/24/19 Due: 04/24/20

Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02108483 Org: User:
Start: 04/30/14 End: 05/31/14 Due: 05/31/15

Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01974323 Org: User:
Start: 11/30/13 End: 10/31/14 Due: 10/31/15

A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02180464 Org: User:
Start: 06/30/14 End: 12/31/14 Due: 12/31/15

Efficacy and Safety of LAS41003 in the Treatment of Superficial Infected Eczema

Phase: N/A Priority: Normal
NCT ID: NCT01020994 Org: User:
Start: 11/30/09 End: 06/30/10 Due: 06/30/11

Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)

Phase: N/A Priority: Normal
NCT ID: NCT04820673 Org: User:
Start: 03/09/21 End: 05/04/22 Due: 05/04/23

A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp

Phase: N/A Priority: Normal
NCT ID: NCT03285477 Org: User:
Start: 09/18/17 End: 04/24/19 Due: 04/24/20

Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients

Phase: N/A Priority: Normal
NCT ID: NCT01385696 Org: User:
Start: 06/30/11 End: 01/31/12 Due: 01/31/13